Pulmonx (LUNG) Analyst & Key Data

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

4

Hold

4

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.85

Median Target+116.22%

$4.00

Potential upside vs current price

DCF Value-585.23%

-$8.98

Potential downside vs current price

Current Stock Price

$1.85

Median Target+116.22%

$4.00

Potential upside vs current price

DCF Value-585.23%

-$8.98

Potential downside vs current price

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

4

Hold

4

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.85

Median Target+116.22%

$4.00

Potential upside vs current price

DCF Value-585.23%

-$8.98

Potential downside vs current price

Current Stock Price

$1.85

Median Target+116.22%

$4.00

Potential upside vs current price

DCF Value-585.23%

-$8.98

Potential downside vs current price

Pulmonx Corporation